Eunyoung Suh

560 total citations
10 papers, 403 citations indexed

About

Eunyoung Suh is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Eunyoung Suh has authored 10 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 2 papers in Surgery. Recurrent topics in Eunyoung Suh's work include Atrial Fibrillation Management and Outcomes (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Acute Myocardial Infarction Research (2 papers). Eunyoung Suh is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Acute Myocardial Infarction Research (2 papers). Eunyoung Suh collaborates with scholars based in United States, Canada and Italy. Eunyoung Suh's co-authors include Jonathan L. Halperin, Alex C. Spyropoulos, Elliot S. Barnathan, Theodore E. Spiro, Gary E. Raskob, Jeffrey I. Weitz, Gregory W. Albers, Philippe Gabríel Steg, Gregory A. Maynard and Walter Ageno and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Eunyoung Suh

8 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eunyoung Suh United States 6 289 254 93 65 51 10 403
Alexander Cohen United States 3 406 1.4× 293 1.2× 61 0.7× 87 1.3× 37 0.7× 4 455
Ruth B. Morrison United States 7 197 0.7× 104 0.4× 153 1.6× 73 1.1× 62 1.2× 9 347
José María Pedrajas Spain 10 228 0.8× 150 0.6× 30 0.3× 55 0.8× 19 0.4× 24 264
Renée Douma Netherlands 7 234 0.8× 116 0.5× 37 0.4× 47 0.7× 20 0.4× 9 304
Fréderic Glauser Switzerland 9 101 0.3× 73 0.3× 40 0.4× 70 1.1× 23 0.5× 23 253
Julia Czuprynska United Kingdom 8 206 0.7× 95 0.4× 159 1.7× 112 1.7× 63 1.2× 15 379
Diane Wirth United States 5 233 0.8× 253 1.0× 21 0.2× 71 1.1× 12 0.2× 12 397
Irfan Moinuddin United States 6 99 0.3× 68 0.3× 20 0.2× 105 1.6× 21 0.4× 14 272
R. Valle Spain 8 221 0.8× 175 0.7× 14 0.2× 85 1.3× 35 0.7× 15 322
Benjamin Crichi France 7 78 0.3× 47 0.2× 50 0.5× 26 0.4× 39 0.8× 18 149

Countries citing papers authored by Eunyoung Suh

Since Specialization
Citations

This map shows the geographic impact of Eunyoung Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunyoung Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunyoung Suh more than expected).

Fields of papers citing papers by Eunyoung Suh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eunyoung Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunyoung Suh. The network helps show where Eunyoung Suh may publish in the future.

Co-authorship network of co-authors of Eunyoung Suh

This figure shows the co-authorship network connecting the top 25 collaborators of Eunyoung Suh. A scholar is included among the top collaborators of Eunyoung Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eunyoung Suh. Eunyoung Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Capell, Warren H., Elliot S. Barnathan, Gregory Piazza, et al.. (2021). Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. American Heart Journal. 235. 12–23. 33 indexed citations
3.
Ageno, Walter, Renato D. Lópes, Mark Goldin, et al.. (2021). Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older. Journal of Thrombosis and Haemostasis. 19(11). 2772–2780. 5 indexed citations
4.
Weitz, Jeffrey I., Gary E. Raskob, Alex C. Spyropoulos, et al.. (2020). Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials. Thrombosis and Haemostasis. 120(3). 515–524. 15 indexed citations
5.
Spyropoulos, Alex C., Concetta Lipardi, Eunyoung Suh, et al.. (2019). Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. Clinical and Applied Thrombosis/Hemostasis. 25. 2873284550–2873284550. 46 indexed citations
6.
Kim, Eun-Jung, et al.. (2019). Illness Experience of Patients with Short Bowel Syndrome. 4. 1–10.
7.
Spyropoulos, Alex C., Alexander T. Cohen, Concetta Lipardi, et al.. (2018). Abstract 10541: Improved Benefit Risk Profile of Rivaroxaban in a MARINER-Like Subpopulation of the MAGELLaN Study. Circulation. 1 indexed citations
8.
Spyropoulos, Alex C., Walter Ageno, Gregory W. Albers, et al.. (2018). Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. New England Journal of Medicine. 379(12). 1118–1127. 164 indexed citations
9.
Lee, Sunmi, et al.. (2015). The Adaptation Experiences of Implantable Cardioverter Defibrillator (ICD) Recipients. 39–39. 1 indexed citations
10.
Sherwood, Matthew W., Christopher C. Nessel, Anne S. Hellkamp, et al.. (2015). Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin. Journal of the American College of Cardiology. 66(21). 2271–2281. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026